Isolated 3-Methylcrotonyl CoA Carboxylase Deficiency Detected by Newborn Screening Program Using Tandem Mass Spectrometry

탠덤매스 신생아 스크리닝 검사로 발견된 Isolated 3-Methylcrotonyl CoA Carboxylase 결핍증 1례

  • Kwak, Ju Young (Department of Pediatrics, Il Sin Christian Hospital) ;
  • Park, Jun Young (Department of Pediatrics, Il Sin Christian Hospital) ;
  • Nam, Kyung A (Department of Pediatrics, Il Sin Christian Hospital) ;
  • Son, Sang Hi (Department of Pediatrics, Il Sin Christian Hospital) ;
  • Seo, Son Sang (Department of Pediatrics, Il Sin Christian Hospital)
  • Received : 2004.07.27
  • Accepted : 2005.01.17
  • Published : 2005.05.15

Abstract

Isolated deficiency of 3-methylcrotonyl CoA carboxylase is a rare disorder of the catabolic pathway for leucine and many patients have mild symptoms or no symptom. However, the introduction of tandem mass spectrometry in newborn screening has revealed an unexpectedly high incidence of this disorder. We report an asymptomatic premature infant with isolated 3-methylcrotonyl CoA carboxylase deficiency detected by newborn screening program using tandem mass spectrometry. She was born at preterm, 36 weeks of gestation and her birth weight was 1,912 gm. She was delivered by Cesarian section due to maternal preeclampsia and oligohydramnios. An elevation of 3-hydroxyisovalerylcarnitine in a blood sample obtained at Seven days was detected by tandem mass screening. Massively elevated excretion of 3-hydroxyisovalerate and 3-methylcrotonylglycine was detected in the urine collected at 15 days. L-carnitine(100 mg/kg/day) was administrated orally to correct sencondary carnitine deficiency. Carnitine is conjugated with metabolites, to decrease the potential toxic effects. She is asymptomatic to date, and her growth and development are within normal limits.

저자들은 탠덤매스를 이용한 신생아 대사질환 스크리닝 검사로 우연히 발견된 무증상의 isolated 3-methylcrotonyl CoA carboxylase 결핍증 1례를 경험하여 이를 보고하는 바이다.

Keywords

References

  1. Visser G, Suorrnala T, Smit P, Reijngoud D, Bink-Boelkens M, Niezen-Koning K, et al. 3-Methylcrotonyl-CoA carboxylase deficiency in an infant with cardiomyopathy, in her brother with developmental delay in their asymptomatic father. Eur J Pediatr 2000;159:901-4 https://doi.org/10.1007/PL00008366
  2. Eldjarn L, Lellum E, Stokke O, Pande H, Waaler PE. \beta-Hydroxyisovaleric aciduria and \beta--Methvlcrotonylglycinuria : a new inborn error of metabolism. Lancet 1970;5:521-2 https://doi.org/10.1016/S0140-6736(02)91191-8
  3. Kim SJ. Maternal metabolic disease detected by newborn screening program using tandem mass. Korean J Inher Metab Dis 2003;3:97-9
  4. Gallardo ME, Desviat LR, Rodriguez JM, Esparza-Gordillo J, Perez-Cerda C, Perez B, et al. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. Am J Hum Genet 2001;68:334-46 https://doi.org/10.1086/318202
  5. Leonard JV, Seakins JWT, Bartlett K, Hyde J, Wilson J, Clayton B. Inherited disorders of 3-methylcrotonyl CoA carboxylation. Arch Dis Child 1981;56:53-9 https://doi.org/10.1136/adc.56.1.53
  6. Van Hove JLK, Rutledge SL, Nada MA, Kahler SG, Millington D. 3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl CoA carboxylase deficiency. J Inher Metab Dis 1995;18: 592-601 https://doi.org/10.1007/BF02436004
  7. Tsai MY, Johnson DD, Sweetman L, Berry SA. Two siblings with biotin-resistant 3-methylcrotonyl-coenzyme A carboxylase deficiency. J Pediatr 1989;115:110-3 https://doi.org/10.1016/S0022-3476(89)80343-9
  8. Elpeleg ON, Havkin S, Barash V, Jakobs C, Glick B, Shalev R. Familial hypotonia of childhood caused by isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency. J Pediatr 1992;121:407-10 https://doi.org/10.1016/S0022-3476(05)81796-2
  9. Beemer FA, Bartlett K, Duran M, Ghneim HK, Wadman SK, Bruinvis L, et al. Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency in two sibs. Eur J Pediatr 1982;138:351-4 https://doi.org/10.1007/BF00442517
  10. Steen C, Baumgartner ER, Duran M, Lehnert W, Suormala T, Fingerhut R, et al. Metabolic stroke in isolated 3-methylcrotonyl-CoA carboxylase deficiency. Eur J Pediatr 1999; 158:730-3 https://doi.org/10.1007/s004310051189
  11. Layward EM, Tanner MS, Pollitt RJ, Barlett K. Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency presenting as a Reye syndrome-like illness. J Inher Metab Dis 1989;12:339-40 https://doi.org/10.1007/BF01799234
  12. Bannwart C, Wermuth B, Baumgartner R, Suormala T, Wiesmann uN. Isolated biotin-resistant deficiency of 3methylcrotonyl-CoA carboxylase presenting as a clinically severe form in a newborn with fatal outcome. J Inher Metab Dis 1992;15:863-8 https://doi.org/10.1007/BF01800223
  13. Lehnert W, Niederhoff H, Suormala T, Baumgartner Er, Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency: long-term outcome in a case with neonatal onset. Eur J Pediatr 1996;155:568-72
  14. Murayama K, Kimura M, Yamaguchi S, Shinka T, Kodama K. Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl. Brain Dev 1997;19:303-5 https://doi.org/10.1016/S0387-7604(97)86920-3
  15. Yap S, Monavari AA, Thornton P, Naughten E. Lateinfantile 3-methylcrotonyl-CoA carboxylase deficiency presenting as global developmental delay. J Inher Metab Dis 1998;21:175-176 https://doi.org/10.1023/A:1005372432116
  16. Gompertz D, Draffan GH, Watts JL, Hull D. Biotin-responsive-rnethvkrotonylglvcinuria. Lancet 1971;2:22-4 https://doi.org/10.1016/S0140-6736(02)83548-6
  17. Pearson MA, Aleck KA, Heidenreich RA. Benign clinical presentation of 3-methylcrotonylglycinuria. J Inher Metab Dis 1995;18:640-1 https://doi.org/10.1007/BF02436012
  18. Rinaldo P, Schmidt-Sommerfeld E, Posca AP, Heales SJR, Woolf DA, Leonard JV. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1993;122:580-4 https://doi.org/10.1016/S0022-3476(05)83539-5
  19. JH Walter. L-carnitine. Arch Dis Child 1996;74:475-8 https://doi.org/10.1136/adc.74.6.475
  20. Ihara K, Kuromaru R, Inoue Y, Kuhara T, Matsumoto I, Yoshino M, et al. An asymptomatic infant with isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency detected by newborn screening for maple syrup urine disease. Eur J Pediatr 1997;156:713-5 https://doi.org/10.1007/s004310050696